Skip to content

Evaluation of genetic instability and cytotoxicity in professionals who work in surgical center of the veterinary hospital and are exposed to isoflurane anesthetic

Evaluation of genetic instability and cytotoxicity in professionals who work in surgical center of the veterinary hospital and are exposed to isoflurane anesthetic

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-3yb4b9
Enrollment
Unknown
Registered
2018-01-25
Start date
2018-03-05
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Occupational Exposure

Interventions

This work will evaluate the concentrations of anesthetic gas residues (RGA) isoflurane and sevoflurane in operating rooms. There will be a single collection of biological material (buccal exfoliative
Other

Sponsors

Faculdade de Medicina de Botucatu - Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP)
Lead Sponsor
Departamento de Anestesiologia
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Have at least one year of operation in the surgical center; surgery of small and large animals; animal husbandry; animal reproduction; sádios volunteers; both genders; age between 18 and 60 years

Exclusion criteria

Exclusion criteria: Carriers of malignant disease; infectious diseases: inflammatory; heavy use of alcohol; of "illicit drugs"; medicines; vitamin supplementation; work in some area with occupational exposure

Design outcomes

Primary

MeasureTime frame
The expected outcome is an increase in DNA damage. The methods of the comet test will be used to evaluate damages and genetic instability by the micronucleus test (MN) method, and cytotoxicity by flow cytometry, where viability and apoptosis and buccal micronucleus will be analyzed, where genomic instability will also be evaluated. Results that achieve a level of 5% will be considered significant. The sample size was calculated based on previous studies with the MN test assuming an expected mean difference between the groups for the buccal MN test around 0.52 and a standard deviation of 0.56, being determined 30 individuals per group with 95% test power.

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactDrielle Figueiredo

Faculdade de Medicina de Botucatu - Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP)

drielle.bap@hotmail.com+55-014-3880-1001

Outcome results

None listed

Source: REBEC (via WHO ICTRP)